Oxytocin in the medial prefrontal cortex attenuates anxiety: Anatomical and receptor specificity and mechanism of action

Neuropharmacology

Volumn 125, Issue , 2017, Pages 1-12

  Sabihi, Sara ^a   Dong, Shirley M ^a   Maurer, Skyler D ^a   Post, Caitlin ^a   Leuner, Benedetta ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Amygdala; Anxiety; GABA; Medial prefrontal cortex; Oxytocin; Prelimbic

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; OXYTOCIN; OXYTOCIN RECEPTOR; VASOPRESSIN RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; VASOPRESSIN RECEPTOR ANTAGONIST;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANTERIOR CINGULATE; ANXIETY; ARTICLE; BASOLATERAL AMYGDALA; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; DRUG MECHANISM; INFRALIMBIC CORTEX; MALE; MEDIAL PREFRONTAL CORTEX; NERVE CELL NETWORK; NERVE CELL STIMULATION; NEUROANATOMY; NEUROMODULATION; NONHUMAN; PRELIMBIC CORTEX; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CINGULATE GYRUS; CYTOLOGY; DRUG EFFECT; DRUG THERAPY; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; PREFRONTAL CORTEX; SPRAGUE DAWLEY RAT; SYNAPTIC TRANSMISSION;

ANIMALS; ANTIDIURETIC HORMONE RECEPTOR ANTAGONISTS; ANXIETY; GABA-A RECEPTOR ANTAGONISTS; GABAERGIC NEURONS; GYRUS CINGULI; MALE; MOTOR ACTIVITY; OXYTOCIN; PREFRONTAL CORTEX; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; RECEPTORS, OXYTOCIN; RECEPTORS, VASOPRESSIN; SYNAPTIC TRANSMISSION;

EID: 85021880658     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2017.06.024     Document Type: Article

References (120)

1. Adhikari, A., Distributed circuits underlying anxiety. Front. Behav. Neurosci., 8, 2014, 112.
2. Albrechet-Souza, L., Borelli, K.G., Carvalho, M.C., Brandao, M.L., The anterior cingulate cortex is a target structure for the anxiolytic-like effects of benzodiazepines assessed by repeated exposure to the elevated plus maze and Fos immunoreactivity. Neuroscience 164 (2009), 387–397.
3. Ayers, L.W., Missig, G., Schulkin, J., Rosen, J.B., Oxytocin reduces background anxiety in a fear-potentiated startle paradigm: peripheral vs central administration. Neuropsychopharmacology 36 (2011), 2488–2497.
4. Bale, T.L., Davis, A.M., Auger, A.P., Dorsa, D.M., McCarthy, M.M., CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior. J. Neurosci. 21 (2001), 2546–2552.
5. Bales, K.L., Kim, A.J., Lewis-Reese, A.D., Carter, C.S., Both oxytocin and vasopressin may influence alloparental behavior in male prairie voles. Horm. Behav. 45 (2004), 354–361.
6. Barberis, C., Tribollet, E., Vasopressin and oxytocin receptors in the central nervous system. Crit. Rev. Neurobiol. 10 (1996), 119–154.
7. Bartz, J.A., Zaki, J., Bolger, N., Ochsner, K.N., Social effects of oxytocin in humans: context and person matter. Trends Cogn. Sci. 15 (2011), 301–309.
8. Becker, A., Grecksch, G., Illumination has no effect on rats’ behavior in the elevated plus maze. Physiol. Behav. 59 (1996), 1175–1177.
9. Benarroch, E.E., Oxytocin and vasopressin: social neuropeptides with complex neuromodulatory functions. Neurology 80 (2013), 1521–1528.
10. Berretta, S., Pantazopoulos, H., Caldera, M., Pantazopoulos, P., Pare, D., Infralimbic cortex activation increases c-Fos expression in intercalated neurons of the amygdala. Neuroscience 132 (2005), 943–953.
11. Bethlehem, R.A., Baron-Cohen, S., van Honk, J., Auyeung, B., Bos, P.A., The oxytocin paradox. Front. Behav. Neurosci., 8, 2014, 48.
12. Bi, L.L., Wang, J., Luo, Z.Y., Chen, S.P., Geng, F., Chen, Y.H., Li, S.J., Yuan, C.H., Lin, S., Gao, T.M., Enhanced excitability in the infralimbic cortex produces anxiety-like behaviors. Neuropharmacology 72C (2013), 148–156.
13. Bissiere, S., McAllister, K.H., Olpe, H.R., Cryan, J.F., The rostral anterior cingulate cortex modulates depression but not anxiety-related behaviour in the rat. Behav. Brain Res. 175 (2006), 195–199.
14. Bissiere, S., Plachta, N., Hoyer, D., McAllister, K.H., Olpe, H.R., Grace, A.A., Cryan, J.F., The rostral anterior cingulate cortex modulates the efficiency of amygdala-dependent fear learning. Biol. Psychiatry 63 (2008), 821–831.
15. Blume, A., Bosch, O.J., Miklos, S., Torner, L., Wales, L., Waldherr, M., Neumann, I.D., Oxytocin reduces anxiety via ERK1/2 activation: local effect within the rat hypothalamic paraventricular nucleus. Eur. J. Neurosci. 27 (2008), 1947–1956.
16. Bosch, O.J., Neumann, I.D., Both oxytocin and vasopressin are mediators of maternal care and aggression in rodents: from central release to sites of action. Horm. Behav. 61 (2012), 293–303.
17. Bossert, J.M., Stern, A.L., Theberge, F.R., Cifani, C., Koya, E., Hope, B.T., Shaham, Y., Ventral medial prefrontal cortex neuronal ensembles mediate context-induced relapse to heroin. Nat. Neurosci. 14 (2011), 420–422.
18. Bowen, M.T., McGregor, I.S., Oxytocin and vasopressin modulate the social response to threat: a preclinical study. Int. J. Neuropsychopharmacol. 17 (2014), 1621–1633.
19. Bowen, M.T., Peters, S.T., Absalom, N., Chebib, M., Neumann, I.D., McGregor, I.S., Oxytocin prevents ethanol actions at delta subunit-containing GABAA receptors and attenuates ethanol-induced motor impairment in rats. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 3104–3109.
20. Brinley-Reed, M., Mascagni, F., McDonald, A.J., Synaptology of prefrontal cortical projections to the basolateral amygdala: an electron microscopic study in the rat. Neurosci. Lett. 202 (1995), 45–48.
21. Calcagnoli, F., Kreutzmann, J.C., de Boer, S.F., Althaus, M., Koolhaas, J.M., Acute and repeated intranasal oxytocin administration exerts anti-aggressive and pro-affiliative effects in male rats. Psychoneuroendocrinology 51 (2015), 112–121.
22. Caldwell, H.K., Neurobiology of sociability. Adv. Exp. Med. Biol. 739 (2012), 187–205.
23. Calhoon, G.G., Tye, K.M., Resolving the neural circuits of anxiety. Nat. Neurosci. 18 (2015), 1394–1404.
24. Cassell, M.D., Freedman, L.J., Shi, C., The intrinsic organization of the central extended amygdala. Ann. N. Y. Acad. Sci. 877 (1999), 217–241.
25. Chini, B., Mouillac, B., Balestre, M.N., Trumpp-Kallmeyer, S., Hoflack, J., Hibert, M., Andriolo, M., Pupier, S., Jard, S., Barberis, C., Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin. FEBS Lett. 397 (1996), 201–206.
26. Cho, M.M., DeVries, A.C., Williams, J.R., Carter, C.S., The effects of oxytocin and vasopressin on partner preferences in male and female prairie voles (Microtus ochrogaster). Behav. Neurosci. 113 (1999), 1071–1079.
27. Cruz, A.P., Frei, F., Graeff, F.G., Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 49 (1994), 171–176.
28. de Oliveira, D.C., Chagas, M.H., Garcia, L.V., Crippa, J.A., Zuardi, A.W., Oxytocin interference in the effects induced by inhalation of 7.5% CO(2) in healthy volunteers. Hum. Psychopharmacol. 27 (2012), 378–385.
29. Duchemin, A., Seelke, A.M., Simmons, T.C., Freeman, S.M., Bales, K.L., Localization of oxytocin receptors in the prairie vole (Microtus ochrogaster) neocortex. Neuroscience 348 (2017), 201–211.
30. Dumais, K.M., Veenema, A.H., Vasopressin and oxytocin receptor systems in the brain: sex differences and sex-specific regulation of social behavior. Front. Neuroendocrinol. 40 (2016), 1–23.
31. Engelmann, M., Ebner, K., Wotjak, C.T., Landgraf, R., Endogenous oxytocin is involved in short-term olfactory memory in female rats. Behav. Brain Res. 90 (1998), 89–94.
32. Feifel, D., MacDonald, K., McKinney, R., Heisserer, N., Serrano, V., A randomized, placebo-controlled investigation of intranasal oxytocin in patients with anxiety. Neuropsychopharmacology 36 (2011), S324–S449.
33. Figueira, R.J., Peabody, M.F., Lonstein, J.S., Oxytocin receptor activity in the ventrocaudal periaqueductal gray modulates anxiety-related behavior in postpartum rats. Behav. Neurosci. 122 (2008), 618–628.
34. File, S.E., Seth, P., A review of 25 years of the social interaction test. Eur. J. Pharmacol. 463 (2003), 35–53.
35. Gabbott, P.L., Warner, T.A., Jays, P.R., Salway, P., Busby, S.J., Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers. J. Comp. Neurol. 492 (2005), 145–177.
36. Gimpl, G., Fahrenholz, F., The oxytocin receptor system: structure, function, and regulation. Physiol. Rev. 81 (2001), 629–683.
37. Gonzalez, L.E., Rujano, M., Tucci, S., Paredes, D., Silva, E., Alba, G., Hernandez, L., Medial prefrontal transection enhances social interaction. I: behavioral studies. Brain Res. 887 (2000), 7–15.
38. Gould, B.R., Zingg, H.H., Mapping oxytocin receptor gene expression in the mouse brain and mammary gland using an oxytocin receptor-LacZ reporter mouse. Neuroscience 122 (2003), 155–167.
39. Grillon, C., Krimsky, M., Charney, D.R., Vytal, K., Ernst, M., Cornwell, B., Oxytocin increases anxiety to unpredictable threat. Mol. Psychiatry 18 (2013), 958–960.
40. Guastella, A.J., Howard, A.L., Dadds, M.R., Mitchell, P., Carson, D.S., A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology 34 (2009), 917–923.
41. Guzman, Y.F., Tronson, N.C., Jovasevic, V., Sato, K., Guedea, A.L., Mizukami, H., Nishimori, K., Radulovic, J., Fear-enhancing effects of septal oxytocin receptors. Nat. Neurosci. 16 (2013), 1185–1187.
42. Hale, M.W., Bouwknecht, J.A., Spiga, F., Shekhar, A., Lowry, C.A., Exposure to high- and low-light conditions in an open-field test of anxiety increases c-Fos expression in specific subdivisions of the rat basolateral amygdaloid complex. Brain Res. Bull. 71 (2006), 174–182.
43. Heinrichs, M., Baumgartner, T., Kirschbaum, C., Ehlert, U., Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol. Psychiatry 54 (2003), 1389–1398.
44. Hicks, C., Jorgensen, W., Brown, C., Fardell, J., Koehbach, J., Gruber, C.W., Kassiou, M., Hunt, G.E., McGregor, I.S., The nonpeptide oxytocin receptor agonist WAY 267,464: receptor-binding profile, prosocial effects and distribution of c-Fos expression in adolescent rats. J. Neuroendocrinol. 24 (2012), 1012–1029.
45. Hoover, W.B., Vertes, R.P., Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat. Brain Struct. Funct. 212 (2007), 149–179.
46. Huber, D., Veinante, P., Stoop, R., Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 308 (2005), 245–248.
47. Insel, T.R., Shapiro, L.E., Oxytocin receptor distribution reflects social organization in monogamous and polygamous voles. Proc. Natl. Acad. Sci. U. S. A. 89 (1992), 5981–5985.
48. Jinks, A.L., McGregor, I.S., Modulation of anxiety-related behaviours following lesions of the prelimbic or infralimbic cortex in the rat. Brain Res. 772 (1997), 181–190.
49. Knapska, E., Maren, S., Reciprocal patterns of c-Fos expression in the medial prefrontal cortex and amygdala after extinction and renewal of conditioned fear. Learn Mem. 16 (2009), 486–493.
50. Knobloch, H.S., Charlet, A., Hoffmann, L.C., Eliava, M., Khrulev, S., Cetin, A.H., Osten, P., Schwarz, M.K., Seeburg, P.H., Stoop, R., Grinevich, V., Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron 73 (2012), 553–566.
51. Kozorovitskiy, Y., Hughes, M., Lee, K., Gould, E., Fatherhood affects dendritic spines and vasopressin V1a receptors in the primate prefrontal cortex. Nat. Neurosci. 9 (2006), 1094–1095.
52. Lahoud, N., Maroun, M., Oxytocinergic manipulations in corticolimbic circuit differentially affect fear acquisition and extinction. Psychoneuroendocrinology 38 (2013), 2184–2195.
53. Lapiz-Bluhm, M.D., Bondi, C.O., Doyen, J., Rodriguez, G.A., Bedard-Arana, T., Morilak, D.A., Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats. J. Neuroendocrinol. 20 (2008), 1115–1137.
54. Lee, P.R., Brady, D.L., Shapiro, R.A., Dorsa, D.M., Koenig, J.I., Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin. Neuropsychopharmacology 30 (2005), 1883–1894.
55. Leuner, B., Caponiti, J.M., Gould, E., Oxytocin stimulates adult neurogenesis even under conditions of stress and elevated glucocorticoids. Hippocampus 22 (2012), 861–868.
56. Leuner, B., Shors, T.J., Stress, anxiety, and dendritic spines: what are the connections?. Neuroscience 251 (2013), 108–119.
57. Likhtik, E., Pelletier, J.G., Paz, R., Pare, D., Prefrontal control of the amygdala. J. Neurosci. 25 (2005), 7429–7437.
58. Lim, M.M., Young, L.J., Neuropeptidergic regulation of affiliative behavior and social bonding in animals. Horm Behav 50 (2006), 506–517.
59. Liu, W., Pappas, G.D., Carter, C.S., Oxytocin receptors in brain cortical regions are reduced in haploinsufficient (+/-) reeler mice. Neurol. Res. 27 (2005), 339–345.
60. Lonstein, J.S., Maguire, J., Meinlschmidt, G., Neumann, I.D., Emotion and mood adaptations in the peripartum female: complementary contributions of gamma-aminobutyric acid and oxytocin. J. Neuroendocrinol. 26 (2014), 649–664.
61. Lukas, M., Toth, I., Reber, S.O., Slattery, D.A., Veenema, A.H., Neumann, I.D., The neuropeptide oxytocin facilitates pro-social behavior and prevents social avoidance in rats and mice. Neuropsychopharmacology 36 (2011), 2159–2168.
62. Maaswinkel, H., Gispen, W.H., Spruijt, B.M., Effects of an electrolytic lesion of the prelimbic area on anxiety-related and cognitive tasks in the rat. Behav. Brain Res. 79 (1996), 51–59.
63. MacDonald, K., Feifel, D., Oxytocins role in anxiety: a critical appraisal. Brain Res. 1580 (2014), 22–56.
64. Mak, P., Broussard, C., Vacy, K., Broadbear, J.H., Modulation of anxiety behavior in the elevated plus maze using peptidic oxytocin and vasopressin receptor ligands in the rat. J. Psychopharmacol. 26 (2012), 532–542.
65. Manning, M., Misicka, A., Olma, A., Bankowski, K., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Corbani, M., Guillon, G., Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics. J. Neuroendocrinol. 24 (2012), 609–628.
66. Manning, M., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Guillon, G., Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. Prog. Brain Res. 170 (2008), 473–512.
67. Marlin, B.J., Mitre, M., D'Amour, J.A., Chao, M.V., Froemke, R.C., Oxytocin enables maternal behaviour by balancing cortical inhibition. Nature 520 (2015), 499–504.
68. McCarthy, M.M., McDonald, C.H., Brooks, P.J., Goldman, D., An anxiolytic action of oxytocin is enhanced by estrogen in the mouse. Physiol. Behav. 60 (1996), 1209–1215.
69. McDonald, A.J., Mascagni, F., Guo, L., Projections of the medial and lateral prefrontal cortices to the amygdala: a Phaseolus vulgaris leucoagglutinin study in the rat. Neuroscience 71 (1996), 55–75.
70. Meyer-Lindenberg, A., Domes, G., Kirsch, P., Heinrichs, M., Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat. Rev. Neurosci. 12 (2011), 524–538.
71. Mihalek, R.M., Banerjee, P.K., Korpi, E.R., Quinlan, J.J., Firestone, L.L., Mi, Z.P., Lagenaur, C., Tretter, V., Sieghart, W., Anagnostaras, S.G., Sage, J.R., Fanselow, M.S., Guidotti, A., Spigelman, I., Li, Z., DeLorey, T.M., Olsen, R.W., Homanics, G.E., Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 12905–12910.
72. Millhouse, O.E., The intercalated cells of the amygdala. J. Comp. Neurol. 247 (1986), 246–271.
73. Mitre, M., Marlin, B.J., Schiavo, J.K., Morina, E., Norden, S.E., Hackett, T.A., Aoki, C.J., Chao, M.V., Froemke, R.C., A distributed network for social cognition enriched for oxytocin receptors. J. Neurosci. 36 (2016), 2517–2535.
74. Myers-Schulz, B., Koenigs, M., Functional anatomy of ventromedial prefrontal cortex: implications for mood and anxiety disorders. Mol. Psychiatry 17 (2012), 132–141.
75. Nakajima, M., Gorlich, A., Heintz, N., Oxytocin modulates female sociosexual behavior through a specific class of prefrontal cortical interneurons. Cell 159 (2014), 295–305.
76. Neumann, I.D., Involvement of the brain oxytocin system in stress coping: interactions with the hypothalamo-pituitary-adrenal axis. Prog. Brain Res. 139 (2002), 147–162.
77. Neumann, I.D., Landgraf, R., Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci. 35 (2012), 649–659.
78. Neumann, I.D., Slattery, D.A., Oxytocin in general anxiety and social fear: a translational approach. Biol. Psychiatry 79 (2016), 213–221.
79. Neumann, I.D., Torner, L., Wigger, A., Brain oxytocin: differential inhibition of neuroendocrine stress responses and anxiety-related behaviour in virgin, pregnant and lactating rats. Neuroscience 95 (2000), 567–575.
80. Ninan, I., Oxytocin suppresses basal glutamatergic transmission but facilitates activity-dependent synaptic potentiation in the medial prefrontal cortex. J. Neurochem. 119 (2011), 324–331.
81. Nuss, P., Anxiety disorders and GABA neurotransmission: a disturbance of modulation. Neuropsychiatr. Dis. Treat. 11 (2015), 165–175.
82. Pare, D., Royer, S., Smith, Y., Lang, E.J., Contextual inhibitory gating of impulse traffic in the intra-amygdaloid network. Ann. N. Y. Acad. Sci. 985 (2003), 78–91.
83. Paxinos, G., Watson, C., The Rat Brain in Stereotaxic Coordinates. 1998, Academic Press, San Diego, CA.
84. Pellow, S., Chopin, P., File, S.E., Briley, M., Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14 (1985), 149–167.
85. Postina, R., Kojro, E., Fahrenholz, F., Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling. Adv. Exp. Med. Biol. 449 (1998), 371–385.
86. Qi, J., Han, W.Y., Yang, J.Y., Wang, L.H., Dong, Y.X., Wang, F., Song, M., Wu, C.F., Oxytocin regulates changes of extracellular glutamate and GABA levels induced by methamphetamine in the mouse brain. Addict. Biol. 17 (2012), 758–769.
87. Qi, J., Yang, J.Y., Wang, F., Zhao, Y.N., Song, M., Wu, C.F., Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement. Neuropharmacology 56 (2009), 856–865.
88. Quirk, G.J., Beer, J.S., Prefrontal involvement in the regulation of emotion: convergence of rat and human studies. Curr. Opin. Neurobiol. 16 (2006), 723–727.
89. Ramos, L., Hicks, C., Kevin, R., Caminer, A., Narlawar, R., Kassiou, M., McGregor, I.S., Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: involvement of the V1A receptor. Neuropsychopharmacology 38 (2013), 2249–2259.
90. Ressler, K.J., Amygdala activity, fear, and anxiety: modulation by stress. Biol. Psychiatry 67 (2010), 1117–1119.
91. Resstel, L.B., Souza, R.F., Guimaraes, F.S., Anxiolytic-like effects induced by medial prefrontal cortex inhibition in rats submitted to the Vogel conflict test. Physiol. Behav. 93 (2008), 200–205.
92. Rey, C.D., Lipps, J., Shansky, R.M., Dopamine D1 receptor activation rescues extinction impairments in low-estrogen female rats and induces cortical layer-specific activation changes in prefrontal-amygdala circuits. Neuropsychopharmacology 39 (2014), 1282–1289.
93. Ring, R.H., Malberg, J.E., Potestio, L., Ping, J., Boikess, S., Luo, B., Schechter, L.E., Rizzo, S., Rahman, Z., Rosenzweig-Lipson, S., Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications. Psychopharmacology 185 (2006), 218–225.
94. Rotzinger, S., Lovejoy, D.A., Tan, L.A., Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides 31 (2010), 736–756.
95. Royer, S., Martina, M., Pare, D., An inhibitory interface gates impulse traffic between the input and output stations of the amygdala. J. Neurosci. 19 (1999), 10575–10583.
96. Sabihi, S., Dong, S.M., Durosko, N.E., Leuner, B., Oxytocin in the medial prefrontal cortex regulates maternal care, maternal aggression and anxiety during the postpartum period. Front. Behav. Neurosci., 8, 2014, 258.
97. Sabihi, S., Durosko, N.E., Dong, S.M., Leuner, B., Oxytocin in the prelimbic medial prefrontal cortex reduces anxiety-like behavior in female and male rats. Psychoneuroendocrinology 45 (2014), 31–42.
98. Saitoh, A., Ohashi, M., Suzuki, S., Tsukagoshi, M., Sugiyama, A., Yamada, M., Oka, J., Inagaki, M., Yamada, M., Activation of the prelimbic medial prefrontal cortex induces anxiety-like behaviors via N-Methyl-D-aspartate receptor-mediated glutamatergic neurotransmission in mice. J. Neurosci. Res. 92 (2014), 1044–1053.
99. Sala, M., Braida, D., Lentini, D., Busnelli, M., Bulgheroni, E., Capurro, V., Finardi, A., Donzelli, A., Pattini, L., Rubino, T., Parolaro, D., Nishimori, K., Parenti, M., Chini, B., Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Biol. Psychiatry 69 (2011), 875–882.
100. Shah, A.A., Sjovold, T., Treit, D., Inactivation of the medial prefrontal cortex with the GABAA receptor agonist muscimol increases open-arm activity in the elevated plus-maze and attenuates shock-probe burying in rats. Brain Res. 1028 (2004), 112–115.
101. Sierra-Mercado, D., Padilla-Coreano, N., Quirk, G.J., Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear. Neuropsychopharmacology 36 (2011), 529–538.
102. Slattery, D.A., Neumann, I.D., Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats. Neuropharmacol 58 (2010), 56–61.
103. Smeltzer, M.D., Curtis, J.T., Aragona, B.J., Wang, Z., Dopamine, oxytocin, and vasopressin receptor binding in the medial prefrontal cortex of monogamous and promiscuous voles. Neurosci. Lett. 394 (2006), 146–151.
104. Smith, A.S., Tabbaa, M., Lei, K., Eastham, P., Butler, M.J., Linton, L., Altshuler, R., Liu, Y., Wang, Z., Local oxytocin tempers anxiety by activating GABAA receptors in the hypothalamic paraventricular nucleus. Psychoneuroendocrinology 63 (2016), 50–58.
105. Sobota, R., Mihara, T., Forrest, A., Featherstone, R.E., Siegel, S.J., Oxytocin reduces amygdala activity, increases social interactions, and reduces anxiety-like behavior irrespective of NMDAR antagonism. Behav. Neurosci. 129 (2015), 389–398.
106. Solati, J., Hajikhani, R., Golub, Y., Activation of GABAA receptors in the medial prefrontal cortex produces an anxiolytic-like response. Acta Neuropsychiatr. 25 (2013), 221–226.
107. Stern, C.A., Do Monte, F.H., Gazarini, L., Carobrez, A.P., Bertoglio, L.J., Activity in prelimbic cortex is required for adjusting the anxiety response level during the elevated plus-maze retest. J. Neurosci. 170 (2010), 214–222.
108. Suzuki, S., Saitoh, A., Ohashi, M., Yamada, M., Oka, J., Yamada, M., The infralimbic and prelimbic medial prefrontal cortices have differential functions in the expression of anxiety-like behaviors in mice. Behav. Brain Res. 304 (2016), 120–124.
109. Tillakaratne, N.J., Medina-Kauwe, L., Gibson, K.M., gamma-Aminobutyric acid (GABA) metabolism in mammalian neural and nonneural tissues. Comp. Biochem. Physiol. A Physiol. 112 (1995), 247–263.
110. Toth, I., Neumann, I.D., Slattery, D.A., Central administration of oxytocin receptor ligands affects cued fear extinction in rats and mice in a timepoint-dependent manner. Psychopharmacol. Berl. 223 (2012), 149–158.
111. Tye, K.M., Prakash, R., Kim, S.Y., Fenno, L.E., Grosenick, L., Zarabi, H., Thompson, K.R., Gradinaru, V., Ramakrishnan, C., Deisseroth, K., Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature 471 (2011), 358–362.
112. Uvnas-Moberg, K., Ahlenius, S., Hillegaart, V., Alster, P., High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male rats. Pharmacol. Biochem. Behav. 49 (1994), 101–106.
113. Veenema, A.H., Neumann, I.D., Central vasopressin and oxytocin release: regulation of complex social behaviours. Prog. Brain Res. 170 (2008), 261–276.
114. Vertes, R.P., Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse 51 (2004), 32–58.
115. Vidal-Gonzalez, I., Vidal-Gonzalez, B., Rauch, S.L., Quirk, G.J., Microstimulation reveals opposing influences of prelimbic and infralimbic cortex on the expression of conditioned fear. Learn Mem. 13 (2006), 728–733.
116. Wang, X. J., Wang, J., Liu, Z. H., Ming, Y., Zhang, S. W., 2011. Increased Posterior Cingulate, Medial Frontal and Decreased Temporal Regional Homogeneity in Depressed Mothers. A Resting-State Functional Magnetic Resonance Study. 2011 International Conference on Environment Science and Biotechnology (Icesb 2011) 8, 737–743.
117. Windle, R.J., Shanks, N., Lightman, S.L., Ingram, C.D., Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 138 (1997), 2829–2834.
118. Yoshida, M., Takayanagi, Y., Inoue, K., Kimura, T., Young, L.J., Onaka, T., Nishimori, K., Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice. J. Neurosci. 29 (2009), 2259–2271.
119. Yosten, G.L., Samson, W.K., The melanocortins, not oxytocin, mediate the anorexigenic and antidipsogenic effects of neuronostatin. Peptides 31 (2010), 1711–1714.
120. Young, K.A., Liu, Y., Gobrogge, K.L., Wang, H., Wang, Z., Oxytocin reverses amphetamine-induced deficits in social bonding: evidence for an interaction with nucleus accumbens dopamine. J. Neurosci. 34 (2014), 8499–8506.